Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > June 2011

« Previous month Next month »

Developments in the pharma manufacturing space

30-Jun-2011 - presents a round up of developments in the pharmaceutical manufacturing space with news from Dendreon, Amcor and Cody Labs.

Glass packaging output picks up after tough 2009

30-Jun-2011 - The glass packaging industry in Europe posted a 3.5 per cent year-on year production increase to 20.7m tonnes in 2010 as output partially recovered from its 2009 slump.

News in brief

Par to reduce sales headcount at Strativa unit

30-Jun-2011 - Par Pharmaceutical will cut 100 jobs at its proprietary products division Strativa Pharmaceuticals as part of a restructuring plan designed to save as much as $12m.

Prosonix secures funding for development of proprietary products

30-Jun-2011 - Prosonix has secured funding to move its pipeline of proprietary mono and multi-component combination respiratory therapies through clinical development.

Pfizer to buy back Akrimax plant and sell or close it by 2013

29-Jun-2011 - US drug giant Pfizer has exercised its option to re-acquire a manufacturing facility in Rouses Point, New York from Akrimax.

DSM adds single-step purification and polishing technique for bioproduction

29-Jun-2011 - DSM Biologicals has launched a new production method designed to streamline downstream processing during biopharmaceutical manufacturing that, it claims, makes making mAB-based drugs more cost effective.

Appointments at Soligenx, Arno Therapeutics, Euthymics and Aeris Therapeutics – People on the move

29-Jun-2011 - presents its latest round up of movements in the pharma sector, including appointments at Soligenx, Arno Therapeutics, Euthymics and Aeris Therapeutics.

CSL receives US FDA warning for GMP violations at vaccine plant

28-Jun-2011 - Australia’s CSL Biotherapies has received a warning letter from the US FDA for GMP deviations at its vaccine production plant in Parkville, Victoria.

News in brief

New CEPs for DSM and Aanjaneya Lifecare

28-Jun-2011 - The European Directorate for the Quality of Medicines and Healthcare (EDQM) issued a new batch of CEP for drug products.

Sanofi opens new vaccine R&D site in Canada

28-Jun-2011 - Sanofi Pasteur has opened a new centre in Canada in an effort to streamline its global vaccine R&D operations.

Gerresheimer to invest €12m in key Czech plant

28-Jun-2011 - Gerresheimer will expand its pharmaceutical packaging plant in the Czech Republic to meet growing demand for plastic systems and to further expand a key training hub.

BioMarin to buy Pfizer’s Shanbally biologics plant

27-Jun-2011 - BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.

PhRMA and GPhA disagree on ‘first to file’ US patent law plan

27-Jun-2011 - The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.

DSA talks social media in pharma at DIA 2011

23-Jun-2011 - Social media can play a role in ensuring that medicines are safe, but regulatory input is needed according to the Drug Safety Alliance (DSA).

Watson adding manufacturing capacity in $44m expansion

23-Jun-2011 - Watson Pharmaceuticals has initiated a $44m (€31m) expansion of its Utah R&D and manufacturing plant for transdermal patches and topical gels.

Novartis starts work on Russian manufacturing plant

23-Jun-2011 - Novartis has started work on a manufacturing plant in St Petersburg in the first stage of a $500m investment in the Russian pharmaceutical industry.

Lonza launches manufacturing for early-phase biologics; Regenicin pays up

22-Jun-2011 - Lonza has launched a new process development and material supply service designed for the discovery and early development market.

Tech & collaboration central to FDA's import quality plan

22-Jun-2011 - The FDA has outlined its plan to ensure the quality of products imported into the US, including working more closely with regulators and industry.

EMA proposes waiving inspection of US plants in some cases

21-Jun-2011 - The EMA has proposed to the FDA that European inspections of US manufacturing plants are waived when certain criteria are met.

Pall expands Allegro mixer range

21-Jun-2011 - Processing technology firm Pall Life Sciences has introduced a 200L version of its Allegro single-use mixer for biopharmaceutical manufacturing.

Catalent and Cevec team on cell line development platform

20-Jun-2011 - Catalent Pharma Solutions and German expression system developer Cevec Pharmaceuticals have partnered to create a cell development service that, they claim, will help drugmakers generate stable lines faster.

FDA sends warning letter to Dr Reddy's API Mexican plant

20-Jun-2011 - Dr Reddy's Mexican API production plant has received an FDA warning letter that details failures to validate analytical methods and other problems.

Grindeks opens Latvian API plant & eyes finished dosages

20-Jun-2011 - Grindeks has opened a 2,300 sq m API production plant in Latvia that will boost UDCA sales to €10m ($14m) a year when at full capacity.

Mystic awarded key manufacturing patent for delivery tech

16-Jun-2011 - Mystic Pharmaceuticals has been awarded a US patent for a manufacturing technology that is critical to its biologics delivery platform.

APP invests $38m to boost injectable generics capacity

16-Jun-2011 - US drugmaker APP Pharmaceuticals will invest $38m to boost its manufacturing capacity for injectable generic drugs at its facility in Grand Island.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...